Balchem Corporation (FRA:BL9B)

Market Cap	4.79B +6.7%
Revenue (ttm)	883.35M +8.8%
Net Income	131.88M +20.5%
EPS	4.05 +20.9%
Shares Out	n/a
PE Ratio	36.30
Forward PE	30.53
Dividend	0.82 (0.56%)
Ex-Dividend Date	Dec 23, 2025

Volume	50
Average Volume	5
Open	146.60
Previous Close	144.10
Day's Range	144.70 - 146.60
52-Week Range	118.60 - 154.80
Beta	n/a
RSI	59.79
Earnings Date	Apr 30, 2026

About Balchem

Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended ...

• Industry: Industrial Organic Chemicals
• Founded: 1967
• Employees: 1,352
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: BL9B

Financial Performance

In 2025, Balchem's revenue was $1.04 billion, an increase of 8.75% compared to the previous year's $953.68 million. Earnings were $154.85 million, an increase of 20.53%.

Financial numbers in USD